We've found
184,457
clinical trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Hepatitis C Clinical Trial
3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
Status: Enrolling
Updated: 5/31/2013
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Dietary Nitrates for Heart Failure (HF)
Status: Enrolling,
Phase
I, II
Updated: 2/6/2018
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Clinical Trial
The Mycophenolate Pregnancy Registry
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Hematology Clinical Trial
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling,
Phase
III
Updated: 1/9/2016
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Status: Enrolling,
Phase
I
Updated: 11/9/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
Status: Enrolling
Updated: 7/24/2013
Click here to add this to my saved trials
Endocrinology Clinical Trial
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Status: Enrolling,
Phase
II
Updated: 1/24/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Genomic Profiling in Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Anaplastic Lymphoma Kinase Clinical Trial
Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Pancreatic Adenocarcinoma Clinical Trial
Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Clinical Trial
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Vitamin D Supplementation in Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Persistent or Recurrent Cutaneous T-Cell Lymphoma Clinical Trial
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and a Pharmacokinetic Enhancer When Administered in Combination in Healthy Subjects
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
T Cell Non-Hodgkin Lymphoma Clinical Trial
A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
We've found
184,457
clinical trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 8/28/2014
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling,
Phase
III
Updated: 8/28/2014
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 5/31/2013
3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
Status: Enrolling
Updated: 5/31/2013
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Clinical Trial
Updated: 2/22/2016
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 2/6/2018
Dietary Nitrates for Heart Failure (HF)
Status: Enrolling,
Phase
I, II
Updated: 2/6/2018
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Clinical Trial
Updated: 8/1/2016
The Mycophenolate Pregnancy Registry
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Hematology Clinical Trial
Updated: 1/9/2016
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
Status: Enrolling,
Phase
III
Updated: 1/9/2016
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 4/7/2014
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Patients With Locally Recurrent or Metastatic Breast Cancer
Status: Enrolling,
Phase
II
Updated: 4/7/2014
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Updated: 11/9/2015
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
Status: Enrolling,
Phase
I
Updated: 11/9/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Updated: 5/15/2013
Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis
Status: Enrolling,
Phase
III
Updated: 5/15/2013
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 7/24/2013
A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
Status: Enrolling
Updated: 7/24/2013
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 1/24/2018
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Status: Enrolling,
Phase
II
Updated: 1/24/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Genomic Profiling in Cancer Patients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Updated: 4/8/2013
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Plaque Psoriasis Clinical Trial
Updated: 4/24/2014
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous SCH 900222/MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (P07771/MK-3222-011)
Status: Enrolling,
Phase
III
Updated: 4/24/2014
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Alzheimer's Disease Clinical Trial
Updated: 10/22/2015
An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)
Status: Enrolling,
Phase
II, III
Updated: 10/22/2015
Click here to add this to my saved trials
Anaplastic Lymphoma Kinase Clinical Trial
Updated: 12/31/1969
Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Updated: 10/3/2012
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Updated: 10/3/2012
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Updated: 10/3/2012
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Updated: 10/3/2012
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Updated: 10/3/2012
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Colorectal Cancer, Metastatic Clinical Trial
Updated: 10/3/2012
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Pancreatic Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Updated: 12/31/1969
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsing Remitting Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Vitamin D Supplementation in Multiple Sclerosis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Abdominal Aortic Aneurysm Clinical Trial
Updated: 12/31/1969
ANCHOR (Aneurysm Treatment Using the Heli-FX Aortic Securement System Global Registry)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 10/3/2012
A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Updated: 11/12/2013
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling,
Phase
III
Updated: 11/12/2013
Click here to add this to my saved trials
Persistent or Recurrent Cutaneous T-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Updated: 12/31/1969
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Updated: 7/22/2013
Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and a Pharmacokinetic Enhancer When Administered in Combination in Healthy Subjects
Status: Enrolling
Updated: 7/22/2013
Click here to add this to my saved trials
T Cell Non-Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Updated: 3/1/2016
Prevalence of Antibodies to Selected Porcine Viruses in Patients With Cystic Fibrosis Receiving Porcine-derived Pancreatic Enzyme Replacement Therapy
Status: Enrolling
Updated: 3/1/2016
Click here to add this to my saved trials